Vascular Induction of a Disintegrin and Metalloprotease 17 by Angiotensin II Through Hypoxia Inducible Factor 1α

Obama, Takashi; Takayanagi, Takehiko; Kobayashi, Tomonori; Bourne, Allison M.; Elliott, Katherine J.; Charbonneau, Martine; Dubois, Claire M.; Eguchi, Satoru
January 2015
American Journal of Hypertension;Jan2015, Vol. 28 Issue 1, p10
Academic Journal
BACKGROUND A disintegrin and metalloprotease 17 (ADAM17) is a membrane-spanning metalloprotease overexpressed in various cardiovascular diseases such as hypertension and atherosclerosis. However, little is known regarding the regulation of ADAM17 expression in the cardiovascular system. Here, we test our hypothesis that angiotensin II induces ADAM17 expression in the vasculature. METHODS Cultured vascular smooth muscle cells were stimulated with 100nM angiotensin II. Mice were infused with 1 μg/kg/minute angiotensin II for 2 weeks. ADAM17 expression was evaluated by a promoter–reporter construct, quantitative polymerase chain reaction, immunoblotting, and immunohistochemistry. RESULTS In vascular smooth muscle cells, angiotensin II increased ADAM17 protein expression, mRNA, and promoter activity. We determined that the angiotensin II response involves hypoxia inducible factor 1α and a hypoxia responsive element. In angiotensin II–infused mice, marked induction of ADAM17 and hypoxia inducible factor 1α was seen in vasculatures in heart and kidney, as well as in aortae, by immunohistochemistry. CONCLUSIONS Angiotensin II induces ADAM17 expression in the vasculatures through a hypoxia inducible factor 1α–dependent transcriptional upregulation, potentially contributing to end-organ damage in the cardiovascular system.


Related Articles

  • LIPITENSION: Interplay between dyslipidemia and hypertension. Dalal, Jamshed J.; Padmanabhan, T. N. C.; Jain, Piyush; Patil, Shiva; Vasnawala, Hardik; Gulati, Ashish // Indian Journal of Endocrinology & Metabolism;Mar2012, Vol. 16 Issue 2, p240 

    The burden of cardiovascular disease (CVD) is increasing worldwide. The increase in the burden is a major concern in developing countries like India. It is well-established that hypertension and dyslipidemia are the two major contributing risk factors for CVD. Various epidemiological studies...

  • A comparison between diuretics and angiotensinreceptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial. Fuchs, Flávio D.; Fuchs, Sandra C.; Moreira, Leila B.; Gus, Miguel; Nóbrega, Antônio C.; Poli-de-Figueiredo, Carlos E.; Mion, Décio; Bortolotto, Luiz; Consolim-Colombo, Fernanda; Nobre, Fernando; Coelho, Eduardo Barbosa; Vilela-Martin, José F.; Moreno, Jr., Heitor; Cesarino, Evandro José; Franco, Roberto; Brandão, Andréa Araujo; de Sousa, Marcos R.; Ribeiro, Antônio Luiz Pinho; Jardim, Paulo Cesar; Neto, Abrahão Afiune // Trials;2011, Vol. 12 Issue 1, p53 

    Background: Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor. The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated. Angiotensin-receptor blockers (ARB) have been the preferential drugs in...

  • The Contribution of Whole Blood Viscosity to the Process of Aortic Valve Sclerosis. Sercelik, Alper; Besnili, Abbas Fikret // Medical Principles & Practice;2018, Vol. 27 Issue 2, p173 

    Objective: We aimed to investigate whether increased whole blood viscosity (WBV) could be an important factor for the occurrence of aortic valve sclerosis (AVS).Subjects and Methods: A total of 209 patients were enrolled in the study. WBV was calculated using the...

  • Early and Late Postnatal Myocardial and Vascular Changes in a Protein Restriction Rat Model of Intrauterine Growth Restriction. Menendez-Castro, Carlos; Fahlbusch, Fabian; Cordasic, Nada; Amann, Kerstin; Münzel, Kathrin; Plank, Christian; Wachtveitl, Rainer; Rascher, Wolfgang; Hilgers, Karl F.; Hartne, Andrea // PLoS ONE;2011, Vol. 6 Issue 5, p1 

    Intrauterine growth restriction (IUGR) is a risk factor for cardiovascular disease in later life. Early structural and functional changes in the cardiovascular system after IUGR may contribute to its pathogenesis. We tested the hypothesis that IUGR leads to primary myocardial and vascular...

  • Inhibiting extracellular matrix metalloproteinase inducer maybe beneficial for diminishing the atherosclerotic plaque instability. Xie, S.; Nie, R.; Wang, J. // Journal of Postgraduate Medicine;Oct2009, Vol. 55 Issue 4, p284 

    Atherosclerotic plaque rupture and local thrombosis activation in the artery cause acute serious incidents such as acute coronary syndrome and stroke. The exact mechanism of plaque rupture remains unclear but excessive degradation of the extracellular matrix scaffold by matrix-degrading...

  • Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells. Mei-Fen Shih; Kuang-Hung Pan; Jong Yuh Cherng // International Journal of Molecular Sciences;2015, Vol. 16 Issue 12, p28800 

    Proliferation and migration of vascular smooth muscle cells (VSMC) are important in the development and/or progression of many cardiovascular diseases, including atherosclerosis. Evidence shows that matrix metalloproteinase (MMP)-2 and MMP-9 are related to the pathogenesis of atherosclerosis....

  • Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits. Li, Yafeng; Zhao, Sihai; Wang, Yanli; Chen, Yulong; Lin, Yan; Zhu, Ninghong; Zheng, Huadong; Wu, Min; Cheng, Daxing; Li, Yandong; Bai, Liang; Fan, Jianglin; Liu, Enqi // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Urotensin II (UII) is a vasoactive peptide composed of 11 amino acids that has been implicated to contribute to the development of cardiovascular disease. The purpose of this study was to investigate whether UII affects the development of atherosclerosis in cholesterol-fed rabbits. UII was...

  • Immunological interrelationships--wound healing to fibrosis. Black, Carol M. // Journal of the Royal Society of Medicine;May1996, Vol. 89 Issue 5, p294P 

    The article summarizes papers presented at a meeting of the Royal Society of Medicine's Section of Clinical Immunology and Allergy on March 1995. The papers focused on immunological interrelationships, including "Wound-healing," by M.W.J. Ferguson, "Pulmonary and cardio-vascular diseases," by R....

  • Presymptomatic Atherosclerosis: Association with Cardiovascular Risk Factors and Role of Inflammatory Mediators. Asmaa M. Ebraheim; Abdelazim M. Reda; Marwa Farghaly; Rania M El-hoseiny; Shaheera El Shafee // Egyptian Journal of Neurology, Psychiatry & Neurosurgery;Apr2013, Vol. 50 Issue 2, p149 

    Background: During the last decade, compelling experimental and clinical evidence has demonstrated that both systemic and local inflammation might play a prominent role in the pathogenesis of atherosclerosis. Objective: Identify risk factors and possible role of inflammatory mediators in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics